Erik Vegt

2.5k total citations
67 papers, 1.7k citations indexed

About

Erik Vegt is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Erik Vegt has authored 67 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Pulmonary and Respiratory Medicine, 27 papers in Surgery and 26 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Erik Vegt's work include Radiopharmaceutical Chemistry and Applications (15 papers), Medical Imaging Techniques and Applications (14 papers) and Urologic and reproductive health conditions (13 papers). Erik Vegt is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (15 papers), Medical Imaging Techniques and Applications (14 papers) and Urologic and reproductive health conditions (13 papers). Erik Vegt collaborates with scholars based in Netherlands, Germany and United States. Erik Vegt's co-authors include Otto C. Boerman, Wim J.G. Oyen, Marion de Jong, Jack F.M. Wetzels, Martin Gotthardt, Rosalinde Masereeuw, Marleen Melis, Simon Horenblas, Wouter V. Vogel and Henk G. van der Poel and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Urology and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Erik Vegt

61 papers receiving 1.7k citations

Peers

Countries citing papers authored by Erik Vegt

Since Specialization

Citations

This map shows the geographic impact of Erik Vegt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik Vegt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik Vegt more than expected).

Fields of papers citing papers by Erik Vegt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erik Vegt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik Vegt. The network helps show where Erik Vegt may publish in the future.

Co-authorship network of co-authors of Erik Vegt

This figure shows the co-authorship network connecting the top 25 collaborators of Erik Vegt. A scholar is included among the top collaborators of Erik Vegt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erik Vegt. Erik Vegt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Multicollinearity and redundancy of the PET radiomic feature set 2025 ·European Radiology ·(unknown), Dennis Vriens, Johan Bussink, Tineke W.H. Meijer, Erik H.J.G. Aarntzen, Christophe M. Deroose, Renaud Lhommel, Nicolas Aide, Christophe Le Tourneau, (unknown), Wim J.G. Oyen, (unknown), Jelle P. Ruurda, Erik Vegt, Lioe‐Fee de Geus‐Oei, Floris H. P. van Velden	0
2	Hepatobiliary scintigraphy and liver function changes in patients with hepatocellular carcinoma treated with 166Ho-radioembolization 2025 ·EJNMMI Research ·(unknown), Maarten L. J. Smits, Karel van Erpecum, Joep de Bruijne, Rutger C. G. Bruijnen, Dave Sprengers, (unknown), Erik Vegt, Jan N.M. IJzermans, Marnix G. E. H. Lam, Arthur J. A. T. Braat	2
3	Intra-arterial PSMA injection using hepatic arterial infusion pump in intrahepatic cholangiocarcinoma: a proof-of-concept study 2024 ·European Radiology Experimental ·(unknown), Erik Vegt, Marcel Segbers, (unknown), Bas Groot Koerkamp, Frederik A. Verburg, Maarten Thomeer	0
4	Holmium-166 radioembolisation dosimetry in HCC 2024 ·European Journal of Nuclear Medicine and Molecular Imaging ·(unknown), Arthur J. A. T. Braat, Karel J. van Erpecum, Joep de Bruijne, Rutger C. G. Bruijnen, Dave Sprengers, (unknown), Erik Vegt, Jan N.M. IJzermans, Sjoerd G. Elias, Marnix G. E. H. Lam, Maarten L. J. Smits	3
5	Dose finding study for unilobar radioembolization using holmium-166 microspheres to improve resectability in patients with HCC: the RALLY protocol 2023 ·BMC Cancer ·(unknown), Marnix G. E. H. Lam, Joep de Bruijne, Maarten L. J. Smits, Arthur J. A. T. Braat, Adriaan Moelker, Erik Vegt, Simeon J. S. Ruiter, Walter Noordzij, Gian Luca Grazi, Giulio Vallati, Roel J. Bennink, Otto M. van Delden, Onno Kranenburg, Jan N.M. IJzermans, Maarten W. Nijkamp, Joris I. Erdmann, Rosa Sciuto, Jeroen Hagendoorn, Inne H.M. Borel Rinkes	3
6	Prognostic Value of [18F]FDG PET Radiomics to Detect Peritoneal and Distant Metastases in Locally Advanced Gastric Cancer—A Side Study of the Prospective Multicentre PLASTIC Study 2023 ·Cancers ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Lioe‐Fee de Geus‐Oei, Nelleke Tolboom, Wobbe O. de Steur, (unknown), Riemer H. J. A. Slart, Richard van Hillegersberg, Peter D. Siersema, Jelle P. Ruurda, Floris H. P. van Velden, Erik Vegt, (unknown)	6
7	Multimodal Therapy Versus Primary Surgery for Gastric and Gastroesophageal Junction Diffuse Type Carcinoma, with a Focus on Signet Ring Cell Carcinoma: A Nationwide Study 2023 ·Annals of Surgical Oncology ·(unknown), Arjen van der Veen, Hylke J.F. Brenkman, Lodewijk A.A. Brosens, Rachel S. van der Post, Rob H.A. Verhoeven, (unknown), Pauline A. J. Vissers, Erik Vegt, Richard van Hillegersberg, Peter D. Siersema, Jelle P. Ruurda	2
8	Prospective Evaluation of FDG-PET/CT for On-treatment Assessment of Response to Neoadjuvant or Induction Chemotherapy in Invasive Bladder Cancer 2022 ·Bladder Cancer ·(unknown), Charlotte S. Voskuilen, (unknown), Maarten L. Donswijk, Annemarie Bruining, Michiel S. van der Heijden, Laura S. Mertens, Kees Hendricksen, Erik Vegt, Bas W.G. van Rhijn	0
9	Staging 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Changes Treatment Recommendation in Invasive Bladder Cancer 2021 ·European Urology Oncology ·Charlotte S. Voskuilen, (unknown), (unknown), Erik Vegt, Maarten L. Donswijk, Annemarie Bruining, Henk G. van der Poel, Simon Horenblas, Kees Hendricksen, Bas W.G. van Rhijn, Laura S. Mertens	30
10	Liver Decompensation as Late Complication in HCC Patients with Long-Term Response following Selective Internal Radiation Therapy 2021 ·Cancers ·(unknown), (unknown), Mark C. Burgmans, Daphne D. D. Rietbergen, Minneke J. Coenraad, Otto M. van Delden, Roel J. Bennink, Tim A. Labeur, Heinz‐Josef Klümpen, Ferry A.L.M. Eskens, Adriaan Moelker, Erik Vegt, Dave Sprengers, Nahid Mostafavi, Jan N.M. IJzermans, R. Bart Takkenberg	5
11	F-18 Fluorodeoxyglucose Positron Emission Tomography with Computed Tomography Has High Diagnostic Value for Pelvic and Distant Staging in Patients with High-risk Penile Carcinoma 2021 ·European Urology Focus ·Sarah R. Ottenhof, Rosa S. Djajadiningrat, Michelle W. J. Versleijen, Maarten L. Donswijk, Vincent van der Noort, Oscar R. Brouwer, Niels M. Graafland, Erik Vegt, Simon Horenblas	11
12	Clinical response assessment on DW-MRI compared with FDG-PET/CT after neoadjuvant chemoradiotherapy in patients with oesophageal cancer 2020 ·European Journal of Nuclear Medicine and Molecular Imaging ·(unknown), Francine E.M. Voncken, Doenja M. J. Lambregts, Monique Maas, Maarten L. Donswijk, Erik Vegt, Leon C. ter Beek, Jolanda M. van Dieren, Johanna W. van Sandick, Berthe M.P. Aleman, Geerard L. Beets, Annemarieke Bartels‐Rutten	9
13	Multimodal hybrid imaging agents for sentinel node mapping as a means to (re)connect nuclear medicine to advances made in robot-assisted surgery 2016 ·European Journal of Nuclear Medicine and Molecular Imaging ·Gijs H. KleinJan, Nynke S. van den Berg, Jeroen de Jong, Esther Wit, (unknown), Erik Vegt, Henk G. van der Poel, Fijs W. B. van Leeuwen	35
14	Sentinel Lymph Node Dissection to Select Clinically Node-negative Prostate Cancer Patients for Pelvic Radiation Therapy: Effect on Biochemical Recurrence and Systemic Progression 2016 ·International Journal of Radiation OncologyBiologyPhysics ·Nikolaos Grivas, Esther Wit, Floris J. Pos, Jeroen de Jong, Erik Vegt, Axel Bex, Kees Hendricksen, Simon Horenblas, Gijs H. KleinJan, Bas van Rhijn, Henk G. van der Poel	15
15	Improving fluorescence-guided sentinel node detection during robot-assisted laparoscopic sentinel node biopsy for prostate cancer 2014 ·European Journal of Nuclear Medicine and Molecular Imaging ·Gijs H. KleinJan, Anke van den Berg, Oscar R. Brouwer, Cenk Acar, Esther Wit, Erik Vegt, (unknown), (unknown), (unknown)	1
16	Optimisation of Fluorescence Guidance During Robot-assisted Laparoscopic Sentinel Node Biopsy for Prostate Cancer 2014 ·European Urology ·Gijs H. KleinJan, Nynke S. van den Berg, Oscar R. Brouwer, Jeroen de Jong, Cenk Acar, Esther Wit, Erik Vegt, Vincent van der Noort, Renato A. Valdés Olmos, Fijs W. B. van Leeuwen, Henk G. van der Poel	82
17	18F-fluorodeoxyglucose–Positron Emission Tomography/Computed Tomography Aids Staging and Predicts Mortality in Patients With Muscle-invasive Bladder Cancer 2014 ·Urology ·Laura S. Mertens, Maria Carmen Mir, Andrew M. Scott, Sze Ting Lee, (unknown), Erik Vegt, Wouter V. Vogel, Rustom P. Manecksha, Damien Bolton, Ian D. Davis, Simon Horenblas, Bas W.G. van Rhijn, Nathan Lawrentschuk	24
18	Detecting primary bladder cancer using delayed ¹⁸ F-2-fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography imaging after forced diuresis 2012 ·Indian Journal of Nuclear Medicine ·Simon Horenblas, Laura S. Mertens, (unknown), Erik Vegt, (unknown), (unknown)	10
19	Nephrotoxicity in Mice After Repeated Imaging Using ¹¹¹In-Labeled Peptides 2010 ·Journal of Nuclear Medicine ·Marleen Melis, Erik Vegt, Mark Konijnenberg, M. Visser, (unknown), Marcel Vermeij, Eric P. Krenning, Otto C. Boerman, Marion de Jong	26
20	Superoxide dismutase: the balance between prevention and induction of oxidative damage 2003 ·Chemico-Biological Interactions ·Gertjan J.M. den Hartog, Guido R.M.M. Haenen, Erik Vegt, W. J. F. van der Vijgh, Aalt Bast	33

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact